Reported cases of cyclical Cushing
Introduction
In 1971 Bailey described a patient with Cushing's syndrome due to a bronchial adenoma in whom there appeared to be cycles of excess cortisol secretion.' Since then a few more cases have been de-scribed2-9 in which regular cycles of excess cortisol production (varying from 12 hours to 85 days) occurred, though in only a few of these cases did cortisol production fall in the troughs to normal values. Cyclical Cushing's syndrome is diagnosed by showing three peaks and two troughs of cortisol production with similar distances between the peaks.'
In virtually all patients with Cushing's syndrome cortisol production is considered to exceed normal at all times.' Exceptions have, however, been described and ascribed to (a) random fluctuations in cortisol secretion, (b) spontaneous remissions of the Cushingoid state, and (c) cyclical patterns of cortisol secretion. Patients with anomalous responses to tests of the hypothalamic-pituitary-adrenal axis, particularly so called paradoxical responses to dexamethasone, have also been described."' In the latter steroid outputs rise rather than fall during dexamethasone administration. The reason for the paradoxical responses has remained ill defined, but Brown et al suggested that they may be due to variable secretion of cortisol rather than to a true effect of dexamethasone on cortisol production. 2 Over the past two years we have seen 14 patients with Cushing's syndrome, nine of whom have provided sequential daily urine samples enabling us to show a cyclical pattern of Cushing's syndrome in five of them. The studies performed to establish cyclical patterns, the response of these patients to bromocriptine and cyproheptadine, and the implications of our studies for the diagnosis of patients with Cushing's syndrome are described here.
Patients and methods
None of the 14 patients drank alcohol to excess. The first patient (case 1) had anomalous responses to low and high dose dexamethasone and was shown to have a cyclical form of Cushing's syndrome secondary to a basophil adenoma of the pituitary (see below). Eight of the remaining 13 patients provided sequential daily urine samples for at least 27 days; the four who were shown to have cyclical Cushing's syndrome (cases 2-5) are also described below. In another two there was considerable variation in the urinary cortisol excretion but a cyclical pattern was not established. Because of their more advanced clinical state we could not study the five other patients in such detail.
Serum samples were stored at -20°C before cortisol concentrations were estimated by a direct radioimmunoassay featuring an iodine -125 radioligand and a solid phase antibody. " For estimating urinary free cortisol the urine was extracted with dichloromethane and the assay for free cortisol performed on the dried solvent residue. " The upper limit of normal was 450 nmoll24 h (163 [tg/24 h). Urinary creatinine was determined by autoanalyser using the Jaffe reaction.'2 The urinary free cortisol:creatinine ratio was calculated by dividing the urinary free cortisol value in nmol/I by the urinary creatinine value in mmol/ 1. An aliquot of either a 24 hour collection of urine or the first specimen of urine passed on rising was estimated after storage at -20°C.
The 24 hour urinary free cortisol:creatinine ratio was compared with the early morning ratio on 46 samples from 46 patients and there was a microscopy had ultrastructural features in keeping with a corticotroph adenoma. Prolonged clinical remission (117 days) has been achieved by transsphenoidal surgery. CASE 
2
A 36 year old woman presented with facial swelling, hirsutism, striae, and weight gain. Twenty one years earlier she had had rapid weight gain and amenorrhoea for three years and had been investigated for Cushing (see table) . During the basal period the serum and urinary free cortisol concentrations were normal but became raised during low dose dexamethasone administration. Afterwards they fell to normal but again rose during high dose dexamethasone administration.
The patient's urinary free cortisol secretion and serum cortisol were then observed for 22 days (fig 1) . The serum and urinary cortisol peaks and nadirs correlated closely with plasma adrenocorticotrophic hormone values, providing evidence for dependence on adrenocorticotrophic hormone. The patient's tiredness and facial plethora were greater when the urinary cortisol x-alues were abnormal. Blood pressure showed no cyclical variation. There were two distinct rhythms in cortisol production. One rhythm consisted of a period of 40 days of excess cortisol production followed by 60-70 days of normal production ( fig 2) . During the period of observation in hospital both the urinary cortisol:creatinine ratio and the urinary free cortisol showed cyclical variation, indicating that the cortisol:creatinine ratio was a valid reflection of cortisol secretion. Within the period of excess cortisol production there was a second rhythm consisting of peaks of cortisol production every three to six days with troughs of normal cortisol production. Since this patient differed from the other four in this respect and since these rhythms made interpretation of drug studies difficult she has been described in detail elsewhere. 13 Neither bromocriptine nor cyproheptadine had an effect on cortisol production. A syndrome at another hospital. At that time she appeared Cushingoid with a bloated face and livid striae; urinary 17-ketosteroids were slightly raised at 13 1 mg/24 h. Some weeks later, however, her appearance and urinary steroid excretion were normal and no further investigations were performed. About every two years over the next 16 years she had periods ofillness lasting for two to three months during which she was emotionally unstable and tadine plus bromocriptine (10 mg daily) interrupted the cyclical pattern or changed the amplitude of the peaks of cortisol production.
Transsphenoidal surgery was unsuccessful and bilateral Idrenalectomy was therefore performed. The glands weighed 16 g and the histological features were of diffuse adrenal hyperplasia. The patient has been well since the operation. CASE 3 A 39 year old woman presented to another hospital in 1981 with palpitations and chest pain. Supraventricular tachycardia was diagnosed and treated. Cushing's syndrome was suspected. On admission to our unit plethora, obesity, moon face, facial hirsutism, livid striae, and skin bruising were noted. Blood pressure was 150/100 mm Hg. There was loss of diurnal variation of serum cortisol. Dexamethasone only partially suppressed the 0800 serum cortisol concentration. At transsphenoidal hypophysectomy in August 1981 a basophil adenoma was removed.
After operation the patient was slow to lose her Cushingoid features. Urinary free cortisol and serum cortisol were variable over 10 months with some values in the normal range. Low dose dexamethasone suppression tests, performed twice after the operation, showed variable results (see nervous. Two years before admission to our unit she noted considerable weight gain and facial swelling. Since then she had had regular episodes of weight gain, nervousness, and inability to cope. These episodes tended to occur premenstrually and her facial appearance fluctuated. On examination on admission to this unit she had mild facial hirsutism and non-livid striae of the thighs. Blood Sequential early morning specimens of urine were collected and analysed for free cortisol:creatinine ratio. unaccompanied bv other symptoms. At the age of 51/2 he was admitted for investigation of weight gain (2-5 kg in 10 days), hypertension (140/70 mm Hg), and glycosuria. At that time the serum cortisol concentration was 520 nmol/I at 0900 and 599 nmol/I at 2300. Twelve days later the 0900 cortisol value was 178 nmol/ 1 and the evening value 186 nmol/ 1. Three months after admission he had a left atrial myxoma removed. Over the next five years intermittent facial and abdominal swelling was recognised by his mother and he sometimes had mildly raised blood pressure. In view of the benign nature of his symptoms and his continued normal growth along the 10th percentile no extensive investigations were undertaken. During this time variable urinary cortisol values of 641, 146, and 88 nmol/24 h were noted. However, at the age of 10 his growth suddenly slowed and there was radiological evidence of reduced bone density of the wrist, lumbar vertebrae, and femora. At 12 years height had fallen to below the third percentile. During a low and high dose dexamethasone suppression test the urinary free cortisol and serum cortisol rose (see table) . Fig 3 shows the results of early morning urinary cortisol:creatinine ratios. When urinary excretion of cortisol was high the plasma adrenocorticotrophic hormone values were higher than on the days when urinary free cortisol was low. Over the next seven months three peaks in cortisol excretion were identified, unrelated to any treatment, at days 61, 134, and 189. After three completed cycles and seven days of normal results a further dexamethasone suppression test increased serum and urinary cortisol values at a time slightly earlier than expected (fig 3) . Cyproheptadine and bromocriptine failed to change the pattern of urinary cortisol secretion. Computerised tomography suggested a filling defect in the pituitary and a basophil adenoma was removed. CASE 
5
A 34 year old woman presented with mild bruising and plethora. Basal urinary free cortisol concentrations were raised and suppressed incompletely during low dose dexamethasone therapy. After the high dose test urinary free cortisol fell to 64 nmol/24 h. Three months later repeat tests gave similar results (see table) . When serum cortisol values were raised plasma adrenocorticotrophin values varied from 20 to 100 ng/l. A conservative policy was adopted with frequent outpatient reviews. Daily early morning specimens of urine for a cortisol:creatinine ratio collected for three months (fig 3) showed a clear cyclical pattern with the cortisol secretion returning to normal several times. Subsequently she developed slight muscle weakness and her face became more plethoric. A computed tomogram of the pituitary suggested the presence of a microadenoma, which was subsequently confirmed surgically.
Discussion
The criteria for diagnosing cyclical Cushing's syndrome have been satisfied in only a few previous cases. D.oes this mean that the disease is extremely rare and that our recent rapid accumulation of cases is a coincidence? This may be so, but there have been several reports of patients with fluctuating urine or plasma cortisol values in whom repeated collections of specimens have not been obtained to establish or disprove a cyclical phenomenon.14-24 Several other workers have reported a paradoxical response to dexamethasone25 '27 but have made no attempt to establish whether there was a cyclical phenomenon. Brown et al did, however, perform prolonged studies after such a paradoxical response and established a diagnosis of cyclical Cushing's disease.2 They also established that the rise in cortisol values during dexamethasone therapy was not secondary to the dexamethasone; it merely coincided with administration of the drug. They concluded that any anomalous responses to dexamethasone should be verified by repeat testing and cyclical Cushing's considered as a differential diagnosis. Two of our five patients had a paradoxical response to dexamethasone. This was noted several times in case 1 (postoperative paradoxical response results not included) and case 4. However, we have not maintained dexamethasone treatment over an extended period to see whether spontaneous independent fluctuations of cortisol still occurred and so cannot state definitely that dexamethasone caused the rise in cortisol concentration. Nevertheless, there remains the possibility that in some patients dexamethasone has an effect on the hypothalamicpituitary axis, causing release of adrenocorticotrophic hormone.
Why do some patients with Cushing's syndrome have cycles in their production of cortisol? Halberg has shown cycles of steroid production in normal people,28 so we might simply be observing an exaggeration of the normal cyclical variation in a subgroup of patients.
Our experience over two years suggests that cyclical Cushing's syndrome is not rare. Although the clinical condition of five of our 14 patients with Cushing's syndrome did not allow us to observe them untreated over an extended period, two did show considerable variation in cortisol production over short periods, though no cycles were established. Our experience suggests that the cyclical form of the disease should be more actively sought. The following are worthwhile clinical clues: variable cortisol values, paradoxical or inconsistent responses to dexamethasone, and a variable clinical syndrome such as that seen in cases 1, 2, and 4. Patients slow to lose clinical features of hypercortisolism should also be screened after transsphenoidal surgery (case 3).
Two of our patients had long periods of normal health or normal cortisol production, which raises the possibility that we may miss the diagnosis of Cushing's syndrome more often than we think. Of interest are reports that at necropsy 20% to 30% of people have a pituitary adenoma29 and 27% of these are basophil in type. 29 The long periods of normal cortisol production also make it difficult either to exclude or to diagnose cortisol overproduction because confirmation demands prolonged daily collections of urine for cortisol estimation. Where the possibility has to be vigorously pursued the mailed early morning specimen of urine is invaluable.
It has been suggested that the dopamine agonist bromocriptine'"' and the serotonin antagonist cyproheptadine may be helpful in the management of some patients with Cushing's disease. 436 Our studies with bromocriptine and cyproheptadine either alone or in combination do not suggest that the dopaminergic and serotoninergic systems are concerned in regulating the cycles. Only the third patient showed a response to the combination of cyproheptadine and bromocriptine but we could not attempt to verify this because of side effects.
In summary, we suggest that cyclical Cushing's syndrome is more common than suspected. syndrome in patients who were sensitive to steroids and had frequent relapses.'" Until 1972 the gonadal toxicity of this drug was not appreciated.4 Subsequent reports, however, have suggested a significant inverse correlation of sperm density with cyclophosphamide dosage."
In adult patients rendered azoospermic by cyclophosphamide recovery of spermatogenesis has been documented for up to four years after treatment, a finding that has obvious implications for fertility counselling and contraceptive advice.9 Little information is available on the long term outcome with respect to recovery of spermatogenesis in patients who were treated with large doses of cyclophosphamide during childhood. In addition, as most childhood patients have been studied either prepubertally or in early adulthood reports on their testicular hormone and gonadotrophin concentrations have been confusing."02
This study correlates gonadal effects with cyclophosphamide dosage in a large, single centre study and documents any recovery of spermatogenesis in patients who were tested and reported on previously.8 In addition, the responses of the sex hormones of such patients were determined.
Patients and methods
Men who were aged 17 or older in 1983 and had been treated with cyclophosphamide for childhood nephrotic syndrome at The Hospital for Sick Children, Toronto, between 1967 and 1976 were considered eligible for this study. Of 70 such patients, 28 were unavailable, two had died in motor vehicle accidents, seven refused to participate, and 33 were included in the study. Three patients were subsequently excluded from analysis owing to chronic renal failure (two patients) or a single testis (one patient).
In the 30 remaining patients histological examination before treatment with cyclophosphamide showed minimal lesions in 27 and focal segmental glomerulosclerosis in three. They had been treated with cyclophosphamide at a dose of2-3 mg/kg body weight/day for a mean of280 days (range 42-556). Thirteen patients had received treatment for a year or longer. Two had undergone two courses of treatment roughly two years apart, and the sum of the two courses was used to calculate the dose of cyclophosphamide.
When reviewed in 1983 all 30 patients were well and free of oedema. The three who had focal segmental glomerulosclerosis continued to have proteinuria with no clinical evidence of nephrosis or serious renal impairment. Two of the six patients with minimal lesions who relapsed after
